Ropeginterferon alfa-2b

  • Part D specialty tier in 80% of formularies (2026Q3)
  • Biologic
  • BESREMi

Therapy management checklist

Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.

Loading the therapy management checklist…

Storage and cold chain

Ropeginterferon alfa-2b: storage and handling

Refrigerate
Yes, as the label states
Label statement
Store in the refrigerator between 36°F to 46°F (2°C to 8°C) in the original carton to protect from light.
Freezing
Do not freeze
Label statement
DO NOT FREEZE.
Room temperature
No allowance stated
Back into the refrigerator
Not addressed
Light
Protect from light
Label statement
Store in the refrigerator between 36°F to 46°F (2°C to 8°C) in the original carton to protect from light.
Shaking
Not addressed

Temperature excursion helper

Answers only from this label's storage statements. It does not judge whether a product is still usable beyond what the label states.

The label does not state a room-temperature allowance for this product.

Entered: 1 day at up to 77°F (25°C).

Store in the refrigerator between 36°F to 46°F (2°C to 8°C) in the original carton to protect from light.
DO NOT FREEZE.

Contact the manufacturer about this product; the label text ClinDose has does not print a phone number for it.

All storage statements on the label (6)
  • Store in the refrigerator between 36°F to 46°F (2°C to 8°C) in the original carton to protect from light.
  • DO NOT FREEZE.
  • Storing BESREMi Store the BESREMi carton in the refrigerator between 36°F to 46°F (2°C to 8°C) (Figure B). .
  • Keep your BESREMi prefilled syringes in their original carton (Figure B) while stored. .
  • Do not freeze the prefilled syringes. .
  • Do not use a prefilled syringe that has been frozen or left in direct sunlight. .

FDA label version 13, effective August 25, 2026. DailyMed

Dosing and titration calendar

Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.

Loading dosing schedules…

Medicare Part D coverage

100%of plans list it
98%of those: prior authorization
0%step therapy
62%quantity limit
97%specialty tier

5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan

Patient assistance

No manufacturer program page is listed for this drug yet.

Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.

For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.